Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C).
作者信息
Zerra Patricia E, Stowell Jennifer, Verkerke Hans, McCoy James, Jones Jayre, Graciaa Sara, Lu Austin, Hussaini Laila, Anderson Evan J, Rostad Christina A, Stowell Sean R, Chonat Satheesh
机构信息
Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University, Atlanta, Georgia, USA.
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
出版信息
Am J Hematol. 2023 May;98(5):E98-E101. doi: 10.1002/ajh.26868. Epub 2023 Feb 13.
Abstract
摘要
相似文献
1
Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C).补体因子H自身抗体导致儿童多系统炎症综合征（MIS-C）中的补体失调。
Am J Hematol. 2023 May;98(5):E98-E101. doi: 10.1002/ajh.26868. Epub 2023 Feb 13.
2
Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study.儿童多系统炎症综合征（MIS-C）的炎症和自身免疫方面：一项前瞻性队列研究。
Viruses. 2024 Jun 12;16(6):950. doi: 10.3390/v16060950.
3
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.儿童重症 COVID-19 肺炎合并多系统炎症综合征伴固有型 IFNAR1 缺陷
J Clin Immunol. 2022 Apr;42(3):471-483. doi: 10.1007/s10875-022-01215-7. Epub 2022 Jan 28.
4
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C.COVID-19 成年和儿科患者以及 MIS-C 患儿中与自身免疫相关的蛋白的自身抗体。
Front Immunol. 2022 Mar 11;13:841126. doi: 10.3389/fimmu.2022.841126. eCollection 2022.
5
Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C.与 COVID-19 引起的 MIS-C 相比，COVID-19 ARDS 患儿的病理生理途径差异。
Nat Commun. 2022 May 2;13(1):2391. doi: 10.1038/s41467-022-29951-9.
6
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.儿童多系统炎症综合征与长新冠：SARS-CoV-2 病毒超抗原假说。
Front Immunol. 2022 Jul 7;13:941009. doi: 10.3389/fimmu.2022.941009. eCollection 2022.
7
Multisystem Inflammatory Syndrome in Children.儿童多系统炎症综合征。
J Emerg Med. 2022 Jan;62(1):28-37. doi: 10.1016/j.jemermed.2021.07.070. Epub 2021 Sep 17.
8
COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C).儿童 COVID-19 相关多系统炎症综合征（MIS-C）。
Adv Exp Med Biol. 2024;1448:409-425. doi: 10.1007/978-3-031-59815-9_28.
9
Multisystem inflammatory syndrome in children.儿童多系统炎症综合征。
Turk J Med Sci. 2021 Dec 17;51(SI-1):3273-3283. doi: 10.3906/sag-2105-342.
10
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.儿童多系统炎症综合征（MIS-C）：希腊人群的全国性合作研究。
Eur J Pediatr. 2024 Apr;183(4):1693-1702. doi: 10.1007/s00431-023-05383-5. Epub 2024 Jan 12.
引用本文的文献
1
Local complement activation and modulation in mucosal immunity.黏膜免疫中的局部补体激活与调节
Mucosal Immunol. 2024 Aug;17(4):739-751. doi: 10.1016/j.mucimm.2024.05.006. Epub 2024 Jun 4.
本文引用的文献
1
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.TIM3+ TRBV11-2 T 细胞和 IFNγ 特征可在巡弋的单核细胞和 CD16+NK 细胞中对 MIS-C 进行描绘。
J Exp Med. 2022 Feb 7;219(2). doi: 10.1084/jem.20211381. Epub 2021 Dec 16.
2
Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome.重症新型冠状病毒肺炎急性呼吸窘迫综合征中的补体抑制
Front Pediatr. 2020 Dec 29;8:616731. doi: 10.3389/fped.2020.616731. eCollection 2020.
3
Complement C5 inhibition in patients with COVID-19 - a promising target?新冠病毒肺炎患者中补体C5抑制——一个有前景的靶点？
Haematologica. 2020 Dec 1;105(12):2847-2850. doi: 10.3324/haematol.2020.260117.
4
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.COVID-19 肺部病理学：来自意大利和纽约市的多机构尸检队列研究。
Mod Pathol. 2020 Nov;33(11):2156-2168. doi: 10.1038/s41379-020-00661-1. Epub 2020 Sep 2.
5
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征（MIS-C）中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
6
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.SARS-CoV-2 刺突蛋白直接激活替代补体途径被因子 D 抑制所阻断。
Blood. 2020 Oct 29;136(18):2080-2089. doi: 10.1182/blood.2020008248.
7
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
8
Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.因子 H 自身抗体与英国和爱尔兰儿童的非典型溶血性尿毒症综合征有关。
Kidney Int. 2017 Nov;92(5):1261-1271. doi: 10.1016/j.kint.2017.04.028. Epub 2017 Jul 24.
9
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.促发血浆置换和免疫抑制治疗可改善儿童抗因子 H 自身抗体相关性溶血尿毒综合征的预后。
Kidney Int. 2014 May;85(5):1151-60. doi: 10.1038/ki.2013.373. Epub 2013 Oct 2.
10
Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.抗因子H自身抗体在溶血尿毒综合征中阻断因子H的C端识别功能。
Blood. 2007 Sep 1;110(5):1516-8. doi: 10.1182/blood-2007-02-071472. Epub 2007 May 10.
Zotero 插件